Annual Accounts Payable
$2.69 M
+$604.00 K+28.97%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual accounts payable is $2.69 million, with the most recent change of +$604.00 thousand (+28.97%) on December 31, 2023.
- During the last 3 years, EVAX annual accounts payable has fallen by -$984.00 thousand (-26.79%).
- EVAX annual accounts payable is now -26.79% below its all-time high of $3.67 million, reached on December 31, 2020.
Performance
EVAX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
N/A
September 1, 2024
Summary
- EVAX quarterly accounts payable is not available.
Performance
EVAX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
EVAX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.0% | - |
| 3 y3 years | -26.8% | - |
| 5 y5 years | +1834.5% | - |
EVAX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.6% | +29.0% | ||
| 5 y | 5-year | -26.8% | +316.3% | ||
| alltime | all time | -26.8% | +4457.6% |
Evaxion Biotech A/S Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $2.56 M(-4.9%) |
| Dec 2023 | $2.69 M(+29.0%) | $2.69 M(+59.6%) |
| Jun 2023 | - | $1.69 M(-19.2%) |
| Dec 2022 | $2.08 M(-26.8%) | $2.08 M(-14.5%) |
| Jun 2022 | - | $2.44 M(-1.9%) |
| Mar 2022 | - | $2.49 M(-12.7%) |
| Dec 2021 | $2.85 M | $2.85 M(+429.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $538.00 K(-65.3%) |
| Jun 2021 | - | $1.55 M(-54.5%) |
| Mar 2021 | - | $3.41 M(-7.2%) |
| Dec 2020 | $3.67 M(+468.6%) | $3.67 M(+144.5%) |
| Sep 2020 | - | $1.50 M(+132.5%) |
| Dec 2019 | $646.00 K(+364.7%) | $646.00 K |
| Dec 2018 | $139.00 K(+135.6%) | - |
| Dec 2017 | $59.00 K | - |
FAQ
- What is Evaxion Biotech A/S annual accounts payable?
- What is the all time high annual accounts payable for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual accounts payable year-on-year change?
- What is the all time high quarterly accounts payable for Evaxion Biotech A/S?
What is Evaxion Biotech A/S annual accounts payable?
The current annual accounts payable of EVAX is $2.69 M
What is the all time high annual accounts payable for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual accounts payable is $3.67 M
What is Evaxion Biotech A/S annual accounts payable year-on-year change?
Over the past year, EVAX annual accounts payable has changed by +$604.00 K (+28.97%)
What is the all time high quarterly accounts payable for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly accounts payable is $3.67 M